Interestingly, an animal model of CKD has shown that removing hepcidin improved anemia, suggesting that in patients whose anemia is mainly due to high hepcidin levels, future therapies that mimic or boost ERFE might prove therapeutic [96]. Here, HAMP is linked to chronic kidney disease.